American Journal of Ophthalmology
Volume 139, Issue 2 , Pages 229-234 , February 2005

The treatment of Primary Acquired Melanosis (PAM) with atypia by topical Mitomycin C

  • Jacob Pe’er, MD

      Affiliations

    • Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
    • Corresponding Author InformationInquiries to Jacob Pe’er, MD, Department of Ophthalmology, Hadassah University Hospital, P.O. Box 12000, 91120 Jerusalem, Israel; fax: +972-2-6428896
    • ,
  • Joseph Frucht-Pery, MD

      Affiliations

    • Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

,Accepted 25 August 2004.

References 

  1. Jakobiec FA , Folberg R , Iwamoto T . Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva . Ophthalmology . 1989;96:147–166
  2. Folberg R , McLean IW , Zimmerman LE . Primary acquired melanosis of the conjunctiva . Hum Pathol . 1985;16:129–135
  3. Ackerman AB , Sood R , Koenig M . Primary acquired melanosis of the conjunctiva is melanoma in situ . Mod Pathol . 1991;4:253–263
  4. Jakobiec FA , Rini FJ , Fraunfelder FT , Brownstein S . Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases . Ophthalmology . 1988;95:1058–1070
  5. Codere F , Brownstein S , Garwood JL , Dresner SC . Carbon dioxide laser treatment of the conjunctiva and the cornea . Ophthalmology . 1988;95:37–45
  6. Liesegang TJ . Pigmented conjunctival and scleral lesions . Mayo Clinic Proc . 1994;69:151–161
  7. Frucht-Pery J , Pe’er J . Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia . Arch Ophthalmol . 1996;114:1261–1264
  8. Werschnik C , Lommatzsch PK . Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis . Klin Monatsbl Augenheilkd . 1998;212:465–468
  9. Finger PT , Czechonska G , Liarikos S . Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia . Br J Ophthalmol . 1998;82:476–479
  10. Demirci H , McCormick SA , Finger PT . Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia (clinical experience with histopathologic observations) . Arch Ophthalmol . 2000;118:885–891
  11. Schmidt M , Maier M , Schmidt T , Klaehsen D , Merte RL . The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02%—case report with follow up of 2 years . Klin Monatsbl Augenheilkd . 2001;218:805–809
  12. Rodriguez-Ares T , Tourino R , De Rojas V , Becerra E , Capeans C . Topical mitomycin C in the treatment of pigmented conjunctival lesions . Cornea . 2003;22:114–117
  13. Yuen VH , Jordan DR , Brownstein S , Dorey MW . Topical mitomycin treatment for primary acquired melanosis of the conjunctiva . Ophthal Plast Reconstr Surg . 2003;19:149–151
  14. Finger PT , Milner MS , McCormick SA . Topical chemotherapy for conjunctival melanoma . Br J Ophthalmol . 1993;77:751–753
  15. Frucht-Pery J , Rozenman Y . Mitomycin C therapy for corneal intraepithelial neoplasia . Am J Ophthalmol . 1994;117:164–168
  16. Frucht-Pery J , Sugar J , Baum J , et al.   Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia (a multicenter experience) . Ophthalmology . 1997;104:2085–2093
  17. Wilson MW , Hungerford JL , George SM , Madreperla SA . Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia . Am J Ophthalmol . 1997;124:303–311
  18. Tseng SH , Tsai YY , Chen FK . Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C . Cornea . 1997;16:595–597
  19. Rozenman Y , Frucht-Pery J . Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C . Cornea . 2000;19:1–6
  20. Daniell M , Maini R , Tole D . Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia . Clin Experiment Ophthalmol . 2002;30:94–98
  21. Frucht-Pery J , Rozenman Y , Pe’er J . Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma . Ophthalmology . 2002;109:548–552
  22. Shields CL , Naseripour M , Shields JA , Eagle RC . Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma . Ophthalmology . 2002;109:2129–2133
  23. de Keizer RJ , de Wolff-Rouendaal D , van Delft JL . Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid . Doc Ophthalmol . 1986;64:31–42
  24. Yeatts RP , Ford JG , Stanton CA , Reed JW . Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea . Ophthalmology . 1995;102:1338–1344
  25. Midena E , Angeli CD , Valenti M , de Belvis V , Boccato P . Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil . Br J Ophthalmol . 2000;84:268–272
  26. Yeatts RP , Engelbrecht NE , Curry CD , Ford JG , Walter KA . 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea . Ophthalmology . 2000;107:2190–2195
  27. Maskin SL . Regression of limbal epithelial dysplasia with topical interferon . Arch Ophthalmol . 1994;112:1145–1146
  28. Vann RR , Karp CL . Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia . Ophthalmology . 1999;106:91–97
  29. Karp CL , Moore JK , Rosa RH . Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b . Ophthalmology . 2001;108:1093–1098
  30. Schechter BA , Schrier A , Nagler RS , Smith EF , Velasquez GE . Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b . Cornea . 2002;21:6–11
  31. Kobayashi A , Yoshita T , Uchiyama K , et al.   Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b . Jpn J Ophthalmol . 2002;46:215–217
  32. Gilman AG , Rall TW , Nies AS , Taylor P . Goodman and Gilman’s The Pharmacological Basis of Therapeutics . 8th ed.. Elmsford, NY: Pergamon Press, Inc; 1990; 1274-1248
  33. Wilson MW , Schelonka LP , Siegel D , Meininger A , Ross D . Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis . Curr Eye Res . 2001;22:348–352
  34. Salomao DR , Mathers WD , Sutphin JE , Cuevas K , Folberg R . Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy . Ophthalmology . 1999;106:1756–1760
  35. Cartsburg O , Kallen C , Hillenkamp J , Sundmacher R , Pomjanski N , Bocking A . Topical mitomycin C and radiation induce conjunctival DNA-polyploidy . Annal Cell Pathol . 2001;23:65–74
  36. McKelvie PA , Daniell M . Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia . Br J Ophthalmol . 2001;85:1115–1119
  37. Billing K , Karagiannis A , Selva D . Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia . Am J Ophthalmol . 2003;136:746–747
  38. Sacu S , Segur-Eltz N , Horvat R , Lukas JR , Zehetmayer M . Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma . Am J Opthalmol . 2003;136:375–377

PII: S0002-9394(04)01071-2

doi: 10.1016/j.ajo.2004.08.065

American Journal of Ophthalmology
Volume 139, Issue 2 , Pages 229-234 , February 2005

Article Tools

* Image Usage & Resolution